OpenLegislation

Division 14.2

United Kingdom

Original text. Later amendments are not shown.

On the sales packaging:

  • F1the name and address of the manufacturer and the name and address of the authorised representative, where the manufacturer does not have a registered place of business in the Community,

  • a description of the device,

  • the purpose of the device,

  • the relevant characteristics for its use,

  • if the device is intended for clinical investigations, the words: ‘exclusively for clinical investigations’,

  • if the device is custom-made, the words: ‘custom-made device’,

  • a declaration that the implantable device is in a sterile condition,

  • the month and year of manufacture,

  • an indication of the time limit for implanting a device safely,

  • the conditions for transporting and staring the device,

  • F2in the case of a device within the meaning of Article 1(4a), an indication that the device contains a human blood derivative.

Annotations

Textual amendments

F1

Substituted by Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market (Text with EEA relevance).

F2

Inserted by Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market (Text with EEA relevance).